ALLG HSANZ Clinical Trials Fellowship

This year alone, 19,400 Australians and 2,500 New Zealanders will be diagnosed with a blood cancer such as leukaemia, lymphoma and myeloma.

Blood cancer can develop in anyone, at any age, at any time – and there are no preventative health measures available to reduce the risk of getting blood cancer.

That’s why the work of the ALLG is so important.

Our mission is to create better treatments and better lives for patients with blood cancers like leukaemia, lymphoma and myeloma.

Since 1973, ALLG researchers have conducted over 160 clinical trials that have had a significant impact on cancer care and directly enabled 12,500 patients across Australia and New Zealand to access new treatments.

The results of ALLG trials have shifted the dial, adding to global knowledge of better treatments and changing the way blood cancers are treated around the world.

In 2023, ALLG marks five decades of impact for patients with haematological malignancies.

But there’s still more to do.

ALLG believes that all patients with blood cancer deserve better and less toxic treatments that help to create better lives, better survival outcomes and potentially, a cure.

ALLG HSANZ Clinical Trials Fellowship

To change the future for blood cancer, we must accelerate research and encourage the next generation of blood cancer researchers to drive new discoveries and better treatments for patients.

In our 50th year, ALLG is pleased to announce the establishment of the ALLG HSANZ Clinical Trials Fellowship.

Developing better cancer treatments and searching for a cure takes research, time, talent and funding to make it possible.

The annual Fellowship Program will provide outstanding early-career researchers a pathway to a career in clinical trial research, through engaging with ALLG trials and translational research that delivers value for patients and science.

Your Support is Crucial to Success

We are asking you to join with our ALLG researchers and community to help us accelerate the impact for patients with blood cancers right now.

We are ambitious, with a goal to raise $210,000 to fund the first three ALLG Fellowships.

We invite you to give a gift towards establishing the ALLG HSANZ Clinical Trials Fellowship.

Now is the time.

ALLG is a registered charitable organisation and does not receive any ongoing funding, relying on the generosity of individuals and organisations to achieve our mission of better treatments and better lives for patients with blood cancers.

Donate Now

You can find all the details of this important campaign in our Fellowship Project Fact Sheet below. Each of our special donors to this important campaign will receive recognition of their donation and feature on our Accelerating Impact Donor Wall.

Kate Halford ALLG

To find out more about the ALLG HSANZ Clinical Trials Fellowship, or to discuss your gift, please contact the ALLG Partnership & Fundraising Manager:

Kate Halford
Senior Manager – Partnerships & Communications
P: 03 8373 9705